Up until recently, there have been limited treatment options for keratoconus. But now, there is a new treatment currently in an FDA study that look promising, collagen cross-linking. Now, with corneal collagen cross-linking (CXL), up to 90% of patients (according to many recent studies) have found that their keratoconus was slowed or stopped altogether in...

Read Article